Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy

NCT01857544 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Retinal Vein Occlusion

Interventions

DRUG: Aflibercept

Sponsor

Tennessee Retina

Collaborators

[object Object]